111 related articles for article (PubMed ID: 8640561)
1. Growth arrest of solid human neuroblastoma xenografts in nude rats by natural IgM from healthy humans.
David K; Ollert MW; Juhl H; Vollmert C; Erttmann R; Vogel CW; Bredehorst R
Nat Med; 1996 Jun; 2(6):686-9. PubMed ID: 8640561
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of in vivo anti-neuroblastoma activity of human natural IgM.
Ollert MW; David K; Vollmert C; Juhl H; Erttmann R; Bredehorst R; Vogel CW
Eur J Cancer; 1997 Oct; 33(12):1942-8. PubMed ID: 9516829
[TBL] [Abstract][Full Text] [Related]
3. A novel metastatic animal model reflecting the clinical appearance of human neuroblastoma: growth arrest of orthotopic tumors by natural, cytotoxic human immunoglobulin M antibodies.
Engler S; Thiel C; Förster K; David K; Bredehorst R; Juhl H
Cancer Res; 2001 Apr; 61(7):2968-73. PubMed ID: 11306475
[TBL] [Abstract][Full Text] [Related]
4. Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a Mr 260,000 antigen.
David K; Ollert MW; Vollmert C; Heiligtag S; Eickhoff B; Erttmann R; Bredehorst R; Vogel CW
Cancer Res; 1999 Aug; 59(15):3768-75. PubMed ID: 10446994
[TBL] [Abstract][Full Text] [Related]
5. Normal human serum contains a natural IgM antibody cytotoxic for human neuroblastoma cells.
Ollert MW; David K; Schmitt C; Hauenschild A; Bredehorst R; Erttmann R; Vogel CW
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4498-503. PubMed ID: 8633097
[TBL] [Abstract][Full Text] [Related]
6. [Natural human IgM-antibodies in neuroblastoma therapy: preliminary findings of a phase I/II clinical trial].
Schmitt C; David K; Hiller J; Schrum J; Bredehorst R; Vogel CW; Löliger C; Erttmann R
Klin Padiatr; 1999; 211(4):314-8. PubMed ID: 10472569
[TBL] [Abstract][Full Text] [Related]
7. Distribution of natural antibody against human neuroblastoma among children with or without neuroblastoma.
Fukuda M; Nozaki C; Ishiguro Y; Horibe K
Med Pediatr Oncol; 2001 Jan; 36(1):147-8. PubMed ID: 11464870
[TBL] [Abstract][Full Text] [Related]
8. Initial characterization of the apoptosis-inducing receptor for natural human anti-neuroblastoma IgM.
David K; Heiligtag S; Ollert MW; Teppke M; Vogel CW; Bredehorst R
Med Pediatr Oncol; 2001 Jan; 36(1):251-7. PubMed ID: 11464898
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of systemic administration of irinotecan against neuroblastoma xenografts.
Thompson J; Zamboni WC; Cheshire PJ; Lutz L; Luo X; Li Y; Houghton JA; Stewart CF; Houghton PJ
Clin Cancer Res; 1997 Mar; 3(3):423-31. PubMed ID: 9815701
[TBL] [Abstract][Full Text] [Related]
10. Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53.
Van Maerken T; Ferdinande L; Taildeman J; Lambertz I; Yigit N; Vercruysse L; Rihani A; Michaelis M; Cinatl J; Cuvelier CA; Marine JC; De Paepe A; Bracke M; Speleman F; Vandesompele J
J Natl Cancer Inst; 2009 Nov; 101(22):1562-74. PubMed ID: 19903807
[TBL] [Abstract][Full Text] [Related]
11. Bovine seminal ribonuclease selectively kills human multidrug-resistant neuroblastoma cells via induction of apoptosis.
Cinatl J; Cinatl J; Kotchetkov R; Vogel JU; Woodcock BG; Matousek J; Pouckova P; Kornhuber B
Int J Oncol; 1999 Nov; 15(5):1001-9. PubMed ID: 10536185
[TBL] [Abstract][Full Text] [Related]
12. PlGF and VEGF-A Regulate Growth of High-Risk MYCN-Single Copy Neuroblastoma Xenografts via Different Mechanisms.
Zins K; Kovatchki D; Lucas T; Abraham D
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669225
[TBL] [Abstract][Full Text] [Related]
13. Naturally occurring humoral cytotoxicity against neuroblastoma (NB) cells in healthy persons and NB patients.
Erttmann R; Schmitt C; Ollert MW; David K; Bredehorst R; Vogel CW
Pediatr Hematol Oncol; 1996; 13(6):545-8. PubMed ID: 8940738
[TBL] [Abstract][Full Text] [Related]
14. Expression of a 260 kDa neuroblastoma surface antigen, the target of cytotoxic natural human IgM: correlation to MYCN amplification and effects of retinoic acid.
David K; Ehrhardt A; Ollert MW; Erttmann R; Bredehorst R; Vogel CW
Eur J Cancer; 1997 Oct; 33(12):1937-41. PubMed ID: 9516828
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin-loaded Fab' fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice.
Pastorino F; Brignole C; Marimpietri D; Sapra P; Moase EH; Allen TM; Ponzoni M
Cancer Res; 2003 Jan; 63(1):86-92. PubMed ID: 12517782
[TBL] [Abstract][Full Text] [Related]
16. Serum protein profiling to identify high-risk neuroblastoma: preclinical relevance of blood-based biomarkers.
Sandoval JA; Turner KE; Hoelz DJ; Rescorla FJ; Hickey RJ; Malkas LH
J Surg Res; 2007 Oct; 142(2):268-74. PubMed ID: 17727886
[TBL] [Abstract][Full Text] [Related]
17. Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma.
Michigami T; Ihara-Watanabe M; Yamazaki M; Ozono K
Cancer Res; 2001 Feb; 61(4):1637-44. PubMed ID: 11245477
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo antitumor activity of liposomal Fenretinide targeted to human neuroblastoma.
Raffaghello L; Pagnan G; Pastorino F; Cosimo E; Brignole C; Marimpietri D; Montaldo PG; Gambini C; Allen TM; Bogenmann E; Ponzoni M
Int J Cancer; 2003 May; 104(5):559-67. PubMed ID: 12594810
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of anti-tumour effects of oral fenretinide (4-HPR) in rats with human neuroblastoma xenografts.
Ponthan F; Lindskog M; Karnehed N; Castro J; Kogner P
Oncol Rep; 2003; 10(5):1587-92. PubMed ID: 12883745
[TBL] [Abstract][Full Text] [Related]
20. Natural antibody against neuroblastoma among Japanese children with or without neuroblastoma.
Fukuda M; Nozaki C; Ishiguro Y; Horibe K
Cancer; 1999 Nov; 86(10):2166-70. PubMed ID: 10570448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
